FDA Issues Warning Against Smartwatches And Rings Claiming Blood Sugar Measurement

The US Food and Drug Administration (FDA) issued a cautionary notice through Jonel Aleccia's report for the Associated Press (AP), advising against the use of smartwatches and rings that purport to measure blood sugar levels without skin penetration for medical purposes.

The FDA's advisory excludes smartwatch apps connected to sensors, such as continuous glucose monitoring systems that directly measure blood sugar levels.

The warning extends to all watches or rings, irrespective of brand, making such claims of noninvasive blood glucose measurement, as the FDA has not sanctioned any such device.

Notably, the FDA's advisory excludes smartwatch apps connected to sensors, such as continuous glucose monitoring systems that directly measure blood sugar levels.

Approximately 37 million Americans grapple with diabetes, a condition marked by the body's inability to effectively regulate blood sugar.

Managing diabetes necessitates regular blood sugar monitoring through finger-prick tests or sensor-based systems. The utilization of unapproved smartwatches and smart ring devices could yield inaccurate blood sugar readings, leading to potentially severe consequences, cautioned Dr. Robert Gabbay of the American Diabetes Association (ADA).

WEEKLY FEATURE : Jose Mari Chan And The Christmas Anthem